These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 2083431)

  • 21. Randomized, double-blind trial of carisoprodol 250 mg compared with placebo and carisoprodol 350 mg for the treatment of low back spasm.
    Serfer GT; Wheeler WJ; Sacks HJ
    Curr Med Res Opin; 2010 Jan; 26(1):91-9. PubMed ID: 19908948
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The efficacy and safety of muscle relaxants in inflammatory arthritis: a Cochrane systematic review.
    Richards BL; Whittle SL; van der Heijde DM; Buchbinder R
    J Rheumatol Suppl; 2012 Sep; 90():34-9. PubMed ID: 22942327
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacotherapeutic agents used in temporomandibular disorders.
    Bal Kucuk B; Tolunay Kaya S; Karagoz Motro P; Oral K
    Oral Dis; 2014 Nov; 20(8):740-3. PubMed ID: 24797246
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A CONTROLLED EVALUATION OF CHLORPHENESIN CARBAMATE IN PAINFUL MUSCULOSKELETAL SYNDROMES.
    ABRUZZI WA
    Clin Med (Northfield); 1964 Feb; 71():329-48. PubMed ID: 15446112
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparative profile of tizanidine in the management of spasticity.
    Lataste X; Emre M; Davis C; Groves L
    Neurology; 1994 Nov; 44(11 Suppl 9):S53-9. PubMed ID: 7970011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analgesic efficacy of diazepam and placebo in patients with temporomandibular disorders: a double blind randomized clinical trial.
    Pramod GV; Shambulingappa P; Shashikanth MC; Lele S
    Indian J Dent Res; 2011; 22(3):404-9. PubMed ID: 22048580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological profile of N-(2,6-DIMETHYLPHENYL)-N-(1-methyl-2pyrrolidinylidene)urea, xilobam, a new centrally acting skeletal muscle relaxant.
    Gardocki JF; Hageman WE; Pruss TP
    Arch Int Pharmacodyn Ther; 1978 Jun; 233(2):326-42. PubMed ID: 99099
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyclobenzaprine: novel centrally acting skeletal muscle relaxant.
    Share NN; McFarlane CS
    Neuropharmacology; 1975 Sep; 14(9):675-84. PubMed ID: 1178121
    [No Abstract]   [Full Text] [Related]  

  • 29. Choosing a skeletal muscle relaxant.
    See S; Ginzburg R
    Am Fam Physician; 2008 Aug; 78(3):365-70. PubMed ID: 18711953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The influence of diazepam on the dosage of muscel-relaxants during anaesthesia.
    Martins HF
    Anaesthesist; 1975 Jan; 24(1):1-5. PubMed ID: 165742
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Electroencephalographic effects of chlorphenesin carbamate, a new central muscle relaxant, in rabbits (author's transl)].
    Watanabe S; Araki H; Kawasaki H; Ueki S
    Nihon Yakurigaku Zasshi; 1977 May; 73(4):479-96. PubMed ID: 908544
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A CONTROLLED COMPARISON OF THREE MUSCLE RELAXANT AGENTS.
    STERN FH
    Clin Med (Northfield); 1964 Feb; 71():367-72. PubMed ID: 15446116
    [No Abstract]   [Full Text] [Related]  

  • 33. Centrally acting skeletal-muscle relaxants.
    Domino EF
    Arch Phys Med Rehabil; 1974 Aug; 55(8):369-73. PubMed ID: 4850933
    [No Abstract]   [Full Text] [Related]  

  • 34. Low-dose cyclobenzaprine versus combination therapy with ibuprofen for acute neck or back pain with muscle spasm: a randomized trial.
    Childers MK; Borenstein D; Brown RL; Gershon S; Hale ME; Petri M; Wan GJ; Laudadio C; Harrison DD
    Curr Med Res Opin; 2005 Sep; 21(9):1485-93. PubMed ID: 16197668
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacologic considerations in the management of temporomandibular disorders.
    Haas DA
    J Can Dent Assoc; 1995 Feb; 61(2):105-9, 112-4. PubMed ID: 7600411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diazepam as an adjuvant analgesic to morphine for pain due to skeletal muscle spasm.
    Srivastava M; Walsh D
    Support Care Cancer; 2003 Jan; 11(1):66-9. PubMed ID: 12527958
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacologic management of temporomandibular joint disorders and chronic head and neck pain.
    Gangarosa LP; Mahan PE; Ciarlone AE
    Cranio; 1991 Oct; 9(4):328-38. PubMed ID: 1820833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The pharmacology of chlorphenesin carbamate, a centrally active muscle relaxant.
    MATTHEWS RJ; DAVANZO JP; COLLINS RJ; van der BROOK MJ
    Arch Int Pharmacodyn Ther; 1963; 143():574-94. PubMed ID: 13933881
    [No Abstract]   [Full Text] [Related]  

  • 39. Utilization Patterns of Skeletal Muscle Relaxants Among Commercially Insured Adults in the United States from 2006 to 2018.
    Li Y; Delcher C; Reisfield GM; Wei YJ; Brown JD; Winterstein AG
    Pain Med; 2021 Oct; 22(10):2153-2161. PubMed ID: 33690860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Mydeton: a centrally acting muscle relaxant drug from Gedeon Richter LTD].
    Kocsis P; Tarnawa I; Kovács G; Szombathelyi Z; Farkas S
    Acta Pharm Hung; 2002; 72(1):49-61. PubMed ID: 12426787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.